OTC · REZNF
Street Capital Inc.
$0.01$0.00 (0.0%)
Street Capital Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · CANL · USD
Stock price, earnings
Quote as of Oct 28, 2026, 08:00 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
CannLabs, Inc.’s quoted price sits in the lower half of its reported 52-week range, 66.67% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow CannLabs, Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 06:11 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
Street Capital Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$1.60$0.00 (0.0%)
Trafalgar International, Inc.’s quoted price sits in the lower half of its reported 52-week range, 52.38% below the high.
$0.01$0.00 (+1.68%)
Green Rain Energy Holdings Inc.’s quoted price sits in the lower half of its reported 52-week range, 80.23% below the high.
$0.00$0.00 (0.0%)
Black Bird Biotech, Inc.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.00$0.00 (0.0%)
Love Hemp Group Plc’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Item 9 Labs Corp.: Healthcare · Drug Manufacturers - Specialty & Generic.
$0.01$0.00 (0.0%)
Adastra Holdings Ltd.’s quoted price sits in the lower half of its reported 52-week range, 65.0% below the high.
$0.00$0.00 (0.0%)
Transnational Cannabis Ltd.’s quoted price sits in the lower half of its reported 52-week range, 96.0% below the high.
